$0.85
+0.00 (+0.26%)
Open$0.83
Previous Close$0.85
Day High$0.86
Day Low$0.82
52W High$36.35
52W Low$13.94
Volume—
Avg Volume178.4K
Market Cap30.82M
P/E Ratio—
EPS$-0.90
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+3,732.3% upside
Current
$0.85
$0.85
Target
$32.64
$32.64
$20.70
$32.64 avg
$34.69
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.67M | 4.58M | 5.07M |
| Net Income | -1,188,285 | -1,151,647 | -1,307,679 |
| Profit Margin | -25.5% | -25.2% | -25.8% |
| EBITDA | -1,613,290 | -1,556,423 | -1,763,687 |
| Free Cash Flow | -995,176 | -1,101,967 | -1,220,171 |
| Rev Growth | -5.2% | +24.2% | +16.9% |
| Debt/Equity | 0.72 | 0.58 | 0.50 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |